Photo from Felipe Couñago/X
Jun 9, 2024, 15:06
Felipe Couñago: Our study on ADC as an early prognostic marker has been accepted in ASTRO
Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X:
“Our study has been accepted in American Society for Radiation Oncology: ‘ADC as an early prognostic marker in patients with ADT+ RT’.
This work will be part of Victor Duque’s doctoral thesis. Victor, great job!
Many thanks to all the people and entities that have made this research possible.”
Source: Felipe Couñago/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54